Error: Could not add to watchlist. X
+ Watchlist

Cepheid

CPHD:US
Acquired
CPHD:US was acquired by DHR:US
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.47
Market Cap (USD)
-
Shares Outstanding (m)
73.480
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.24%
% Price Change
+0.16%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Cepheid operates as a molecular diagnostics company. The Company offers medical products, systems, and services for critical infectious diseases and oncology, as well as reimbursement support, industrial reagents, research programs, and accessories. Cepheid markets its products globally.
Address
904 Caribbean Drive
Sunnyvale, CA 94089
United States
Phone
1-408-541-4191
Show More